Article: Research and Markets: Metabolic Syndrome: Pipeline Analysis and U.S. Market Forecast.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c12511) has announced the addition of Metabolic Syndrome: Pipeline Analysis and U.S. Market Forecast to their offering

This is a thorough evaluation of marketed therapies and drugs in development for obesity, dyslipidemia, type 2 diabetes, and hypertension.

Metabolic Syndrome is a cluster of risk factors for atherosclerotic disease and type 2 diabetes mellitus comprising obesity, insulin resistance, hypertension, and dyslipidemia. The eligible treatment population in the U.S. for these four conditions is currently 40 million patients and will nearly double over the next ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!